Contrast Media Global Market Report 2022: Migration to Value Based Care Throws the Focus on Quality & Value of Imaging & Its Ability to Improve Patient Care by Providing Better Quality Images - ResearchAndMarkets.com
Contrast agents help in advanced visualization of biological structures; and helps capture hard-to-image anatomical regions. They help eliminate errors caused by radiologist`s perception which tends to influence interpretation of the true structure of the underlying anatomy. Oral, intravenous, rectal, and intrathecal contrast agents are indispensable today in the practice of radiology for their most primary benefit which is enhanced visibility of internal structures
DUBLIN--(BUSINESS WIRE)--Oct 24, 2022--
The "Contrast Media - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Contrast Media Market to Reach $5.4 Billion by 2026
Contrast agents help in advanced visualization of biological structures; and helps capture hard-to-image anatomical regions. They help eliminate errors caused by radiologist`s perception which tends to influence interpretation of the true structure of the underlying anatomy. Oral, intravenous, rectal, and intrathecal contrast agents are indispensable today in the practice of radiology for their most primary benefit which is enhanced visibility of internal structures.
Efficiency of contrast media over the years has evolved from high-osmolar contrast media (HOCM) which have limited utility and higher side-effects to low-osmolality contrast agents which are safer and preferred for pediatric patients. Amid the COVID-19 crisis, the global market for Contrast Media estimated at US$4.8 Billion in the year 2022, is projected to reach a revised size of US$5.4 Billion by 2026, registering a compounded annual growth rate (CAGR) of 2.9% over the period.
The United States represents the largest regional market for Contrast Media and is projected to reach US$2.1 Billion by 2026. China is expected to spearhead growth and emerge as the fastest growing regional market with a CAGR of 4.3% over the period.
Growth in the global market is set to be driven by prevalence of chronic diseases among the growing global population, aging population, and rise of nuclear medicine. There is strong demand for radioactive contrast agents, also known as radioactive agent, radioactive dye or radiopharmaceutical. Demand is hugely supported by the rise of nuclear medicine. These radioactive materials help diagnose and treat a wide variety of diseases and disorders.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/a1i8uq
View source version on businesswire.com:https://www.businesswire.com/news/home/20221024005475/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: RADIOLOGY HEALTH TECHNOLOGY HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 10/24/2022 04:37 AM/DISC: 10/24/2022 04:37 AM
http://www.businesswire.com/news/home/20221024005475/en
